Fayyad, Rana

Quality-of-Life Impairment in Depressive and Anxiety Disorders

Rapaport, M. H., Clary, C., Fayyad, R., & Endicott, J. (2005) · American Journal of Psychiatry

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesTreatment of Major Depression

Cited by 914

Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the TNT Trial

Vallejo-Vaz, A. J., Fayyad, R., Boekholdt, S. M., Hovingh, G. K., Kastelein, J. J., Melamed, S., Barter, P., Waters, D. D., & Ray, K. K. (2018) · Circulation

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 187

Plasma triglycerides and cardiovascular events in the Treating to New Targets and Incremental Decrease in End-Points through Aggressive Lipid Lowering trials of statins in patients with coronary artery disease

Faergeman, O., Holme, I., Fayyad, R., Bhatia, S., Grundy, S. M., Kastelein, J. J. P., LaRosa, J. C., Larsen, M. L., Lindahl, C., Olsson, A. G., et al. (2009) · The American Journal of Cardiology

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 154

Differential blood pressure effects of ibuprofen, naproxen, and celecoxib in patients with arthritis: the PRECISION-ABPM (Prospective Randomized Evaluation of Celecoxib Integrated Safety Versus Ibuprofen or Naproxen Ambulatory Blood Pressure Measurement) Trial

Ruschitzka, F., Borer, J. S., Krum, H., Flammer, A. J., Yeomans, N. D., Libby, P., Lüscher, T. F., Solomon, D. H., Husni, M. E., Graham, D. Y., et al. (2017) · European Heart Journal

Inflammatory mediators and NSAID effectsBlood Pressure and Hypertension Studies

Cited by 130

Focused Atorvastatin Therapy in Managed-Care Patients With Coronary Heart Disease and CKD

Koren, M. J., Davidson, M. H., Wilson, D. J., Fayyad, R. S., Zuckerman, A., & Reed, D. P. (2009) · American Journal of Kidney Diseases

Lipoproteins and Cardiovascular HealthBlood Pressure and Hypertension Studies

Cited by 115

Clinical correlates of poor sleep quality in posttraumatic stress disorder

Germain, A., Buysse, D. J., Shear, M. K., Fayyad, R., & Austin, C. (2004) · Journal of Traumatic Stress

Sleep and related disordersPosttraumatic Stress Disorder Research

Cited by 107

Prevalence, Predictors, and Outcomes in Treatment-resistant Hypertension in Patients with Coronary Disease

Bangalore, S., Fayyad, R., Laskey, R., DeMicco, D. A., Deedwania, P., Kostis, J. B., & Messerli, F. H. (2014) · The American Journal of Medicine

Blood Pressure and Hypertension StudiesCardiovascular Health and Disease Prevention

Cited by 93

2013 Cholesterol Guidelines Revisited: Percent LDL Cholesterol Reduction or Attained LDL Cholesterol Level or Both for Prognosis?

Bangalore, S., Fayyad, R., Kastelein, J. J., Laskey, R., Amarenco, P., DeMicco, D. A., & Waters, D. D. (2016) · The American Journal of Medicine

Lipoproteins and Cardiovascular HealthCancer, Lipids, and Metabolism

Cited by 51

High-dose atorvastatin is superior to moderate-dose simvastatin in preventing peripheral arterial disease

Stoekenbroek, R. M., Boekholdt, S. M., Fayyad, R., Laskey, R., Tikkanen, M. J., Pedersen, T. R., & Hovingh, G. K. (2015) · Heart

Lipoproteins and Cardiovascular HealthPeripheral Artery Disease Management

Cited by 44

Early, intensive statin treatment reduces ‘hard’ cardiovascular outcomes after acute coronary syndrome

Schwartz, G. G., Fayyad, R., Szarek, M., DeMicco, D., & Olsson, A. G. (2017) · European Journal of Preventive Cardiology

Lipoproteins and Cardiovascular HealthAcute Myocardial Infarction Research

Cited by 44

The effect of desvenlafaxine on cognitive functioning in employed outpatients with major depressive disorder: a substudy of a randomized, double-blind, placebo-controlled trial

Reddy, S., Fayyad, R., Edgar, C. J., Guico-Pabia, C. J., & Wesnes, K. (2016) · Journal of Psychopharmacology

Treatment of Major DepressionSchizophrenia research and treatment

Cited by 17

On-treatment lipoprotein components and risk of cerebrovascular events in the Treating to New Targets study

van den Bogaard, B., van den Born, B.-J. H., Fayyad, R., Waters, D. D., DeMicco, D. A., LaRosa, J. C., Kastelein, J. J. P., Holme, I., & On behalf of the Treating to New Targets investigators (2011) · European Journal of Clinical Investigation

Lipoproteins and Cardiovascular HealthAcute Ischemic Stroke Management

Cited by 12